Trending
September 19, 2023 Magnet Biomedicine Raises $50MSeptember 19, 2023 Interview with Adam Low, CEO of SENTA PartnersAugust 14, 2023 Osage University-backed Dracen Pharma Secures $2.3 Million in DebtJune 6, 2023 Ryan Specialty To Acquire Point6 HealthcareApril 11, 2023 Recuro Health Closes $47 Million Series B Financing Led by ARCH Venture Partners
Featured

September 19, 2023
Magnet Biomedicine Raises $50M
Magnet Biomedicine, a Cambridge, MA-based biotechnology company advancing molecular glue discovery with rational... Read more »

September 19, 2023
Interview with Adam Low, CEO of SENTA Partners
Adam joined SENTA partners on May 6, 2019 as its Chief Executive Officer. In this role, Adam is responsible for the... Read more »

August 14, 2023
Osage University-backed Dracen Pharma Secures $2.3 Million in Debt
Dracen Pharmaceuticals, which is developing a novel drug to treat tumors, last week secured $2.3 million in debt... Read more »